What is Scilex Holding Company's earnings per share (EPS)?

Scilex Holding Company (SCLXW) reported diluted earnings per share of $-36.48 for fiscal year 2025. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Scilex Holding Company Financials

SCLXW

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Scilex Holding Company (SCLXW) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI SCLXW FY2025 2026-04-22

Positive cash flow is masking a loss-making core inside a liability-funded balance sheet with almost no reinvestment needs.

Across FY2024 and FY2025, free cash flow stayed positive at $19.3M and $3.7M. Because gross profit was negative in both years while net losses widened from $72.8M to $374.1M, that cash is being created mainly by non-cash charges and working-capital movements, not by profitable sales; the cash flow line and income statement are describing very different realities.

The short-term funding picture is tighter than the cash-flow line suggests: FY2025 cash was only $5.0M against $483.7M of current liabilities, leaving a current ratio of 0.08x. That ratio worsened from 0.16x in FY2024, which means near-term obligations are building faster than liquid resources.

The cost base is detached from sales scale: FY2025 SG&A burden reached $266.9M against revenue of only $30.3M, after the prior year already showed negative gross profit. With capital expenditures just $133K, the business is not cash-hungry because of physical assets; pressure is coming from overhead and financing structure.

Financial Health Signals

Financial Profile 24/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Scilex Holding Company's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Scilex Holding Company has an operating margin of -1143.7%, meaning the company retains $-1144 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is down from -147.4% the prior year.

Growth

Scilex Holding Company's revenue declined 46.5% year-over-year, from $56.6M to $30.3M. This contraction results in a growth score of 1/100.

Leverage

100

Scilex Holding Company carries a low D/E ratio of -2.78, meaning only $-2.78 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

Scilex Holding Company's current ratio of 0.08 is below the typical benchmark, resulting in a score of 0/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow

Scilex Holding Company has a free cash flow margin of 12.2%, earning a moderate score of 44/100. The company generates positive cash flow after capital investments, but with room for improvement.

Piotroski F-Score Weak

3/9

Scilex Holding Company passes 3 of 9 financial strength tests. 2 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Mixed

-0.01x

For every $1 of reported earnings, Scilex Holding Company generates $-0.01 in operating cash flow ($3.8M OCF vs -$374.1M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Interest Coverage At Risk

-30.2x

Scilex Holding Company earns $-30.2 in operating income for every $1 of interest expense (-$346.0M vs $11.5M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$30.3M

YoY-46.5%

Scilex Holding Company generated $30.3M in revenue in fiscal year 2025. This represents a decrease of 46.5% from the prior year.

EBITDA

-$341.4M

YoY-330.2%

Scilex Holding Company's EBITDA was -$341.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 330.2% from the prior year.

Net Income

-$374.1M

YoY-413.8%

Scilex Holding Company reported -$374.1M in net income in fiscal year 2025. This represents a decrease of 413.8% from the prior year.

EPS (Diluted)

$-36.48

Scilex Holding Company earned $-36.48 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 353.2% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$3.7M

YoY-81.0%

Scilex Holding Company generated $3.7M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 81.0% from the prior year.

Cash & Debt

$5.0M

YoY+51.4%

5Y CAGR+176.8%

Scilex Holding Company held $5.0M in cash against $0 in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

Scilex Holding Company had 7M shares outstanding in fiscal year 2025. This represents a decrease of 97.1% from the prior year.

Margins & Returns

Gross Margin

-218.2%

YoY-122.3pp

Scilex Holding Company's gross margin was -218.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 122.3 percentage points from the prior year.

Operating Margin

-1143.7%

YoY-996.3pp

Scilex Holding Company's operating margin was -1143.7% in fiscal year 2025, reflecting core business profitability. This is down 996.3 percentage points from the prior year.

Net Margin

-1236.4%

YoY-1107.8pp

Scilex Holding Company's net profit margin was -1236.4% in fiscal year 2025, showing the share of revenue converted to profit. This is down 1107.8 percentage points from the prior year.

Return on Equity

N/A

Capital Allocation

R&D Spending

$20.7M

YoY+114.8%

Scilex Holding Company invested $20.7M in research and development in fiscal year 2025. This represents an increase of 114.8% from the prior year.

Share Buybacks

N/A

Capital Expenditures

$133K

5Y CAGR+39.7%

Scilex Holding Company invested $133K in capex in fiscal year 2025, funding long-term assets and infrastructure.

SCLXW Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$30.3M-46.5%	$56.6M+21.1%	$46.7M+22.9%	$38.0M+21.4%	$31.3M	N/A
Cost of Revenue	$96.3M-13.2%	$110.8M+606.9%	$15.7M+45.2%	$10.8M+197.1%	$3.6M	N/A
Gross Profit	-$66.0M-21.7%	-$54.3M-274.7%	$31.1M+14.0%	$27.2M-1.6%	$27.7M	N/A
R&D Expenses	$20.7M+114.8%	$9.6M-24.4%	$12.7M+40.8%	$9.1M-1.6%	$9.2M	N/A
SG&A Expenses	$266.9M+124.2%	$119.0M-0.5%	$119.6M+84.4%	$64.9M+28.3%	$50.6M	N/A
Operating Income	-$346.0M-314.9%	-$83.4M+20.9%	-$105.4M-108.2%	-$50.6M-41.3%	-$35.8M	N/A
Interest Expense	$11.5M+483.7%	$2.0M+83.8%	$1.1M-88.9%	$9.6M-18.4%	$11.8M	N/A
Income Tax	$26K+2700.0%	-$1K-107.7%	$13K+225.0%	$4K-20.0%	$5K+109.4%	-$53K
Net Income	-$374.1M-413.8%	-$72.8M+36.3%	-$114.3M-389.3%	-$23.4M+73.6%	-$88.4M	N/A
EPS (Diluted)	$-36.48	$-8.05-528.9%	$-1.28-652.9%	$-0.17	$-0.67	$-0.36

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Revenue	$4.8M-54.6%	$10.6M+6.7%	$9.9M+97.8%	$5.0M-66.4%	$14.9M+3.2%	$14.4M-11.8%	$16.4M+50.4%	$10.9M
Cost of Revenue	$88.3M+2551.8%	$3.3M+1.7%	$3.3M+136.4%	$1.4M-98.6%	$98.8M+2523.4%	$3.8M-14.2%	$4.4M+14.3%	$3.8M
Gross Profit	-$83.5M-1254.5%	$7.2M+9.2%	$6.6M+83.0%	$3.6M+104.3%	-$84.0M-886.9%	$10.7M-11.0%	$12.0M+70.1%	$7.0M
R&D Expenses	$8.2M+109.5%	$3.9M-37.0%	$6.2M+151.9%	$2.5M+12.7%	$2.2M-7.2%	$2.3M+17.2%	$2.0M-35.5%	$3.1M
SG&A Expenses	$30.2M-84.0%	$188.8M+851.7%	$19.8M-29.3%	$28.1M-20.7%	$35.4M+19.1%	$29.7M+20.9%	$24.6M-16.0%	$29.3M
Operating Income	-$111.1M+40.4%	-$186.5M-809.5%	-$20.5M+26.5%	-$27.9M+1.7%	-$28.4M-42.5%	-$19.9M-27.5%	-$15.6M+19.8%	-$19.5M
Interest Expense	$3.5M+25.0%	$2.8M+4.3%	$2.7M+8.1%	$2.5M+770.5%	$285K-50.5%	$576K+0.9%	$571K+7.5%	$531K
Income Tax	N/A	$1K-94.7%	$19K	N/A	-$1K	$0	$0	$0
Net Income	-$46.1M+82.1%	-$257.8M-485.3%	-$44.0M-68.9%	-$26.1M-303.7%	-$6.5M-47.2%	-$4.4M+88.3%	-$37.6M-54.2%	-$24.4M
EPS (Diluted)	N/A	$-22.17-198.8%	$-7.42	$-2.26	N/A	$-0.58+92.4%	$-7.67+7.9%	$-8.33

SCLXW Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$365.0M+292.7%	$93.0M-8.2%	$101.3M+17.1%	$86.5M+11.0%	$77.9M+38966.8%	$199K
Current Assets	$38.4M-7.7%	$41.5M-11.2%	$46.8M+58.0%	$29.6M+28.7%	$23.0M+75292.5%	$31K
Cash & Equivalents	$5.0M+51.4%	$3.3M-16.6%	$3.9M+79.5%	$2.2M-49.7%	$4.3M+14117.8%	$31K
Inventory	$4.8M+96.6%	$2.4M-42.2%	$4.2M+205.8%	$1.4M-46.2%	$2.6M	N/A
Accounts Receivable	$15.2M-42.3%	$26.4M-23.6%	$34.6M+62.9%	$21.2M+48.8%	$14.3M	N/A
Goodwill	$13.5M0.0%	$13.5M0.0%	$13.5M0.0%	$13.5M0.0%	$13.5M	N/A
Total Liabilities	$576.7M+101.9%	$285.6M+4.1%	$274.2M+445.4%	$50.3M-83.3%	$301.8M+166866.1%	$181K
Current Liabilities	$483.7M+86.3%	$259.6M+3.7%	$250.4M+458.4%	$44.8M-73.5%	$169.4M+93626.5%	$181K
Long-Term Debt	N/A	N/A	N/A	$0-100.0%	$72.0M	N/A
Total Equity	-$207.8M-7.9%	-$192.6M-11.4%	-$172.9M-577.2%	$36.2M+116.2%	-$223.9M-1195763.3%	$19K
Retained Earnings	-$921.8M-63.7%	-$563.1M-14.9%	-$490.2M-30.4%	-$375.9M-6.6%	-$352.6M-5617331.5%	-$6K

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Total Assets	$365.0M+32.3%	$275.9M+229.4%	$83.8M+6.1%	$79.0M-15.0%	$93.0M-7.4%	$100.4M-3.9%	$104.5M+14.6%	$91.2M
Current Assets	$38.4M+132.7%	$16.5M-51.0%	$33.7M+17.3%	$28.7M-30.9%	$41.5M+4.2%	$39.9M-21.0%	$50.4M+33.6%	$37.7M
Cash & Equivalents	$5.0M+464.4%	$878K-78.6%	$4.1M-29.3%	$5.8M+77.3%	$3.3M+4149.4%	$77K-98.9%	$6.9M+278.9%	$1.8M
Inventory	$4.8M+342.6%	$1.1M-57.0%	$2.5M-16.5%	$3.0M+23.9%	$2.4M+1.3%	$2.4M-21.8%	$3.1M-11.8%	$3.5M
Accounts Receivable	$15.2M+27.7%	$11.9M-28.8%	$16.8M+57.9%	$10.6M-59.8%	$26.4M-16.3%	$31.6M-16.9%	$38.0M+27.9%	$29.7M
Goodwill	$13.5M0.0%	$13.5M0.0%	$13.5M0.0%	$13.5M0.0%	$13.5M0.0%	$13.5M0.0%	$13.5M0.0%	$13.5M
Total Liabilities	$576.7M+26.6%	$455.6M+36.9%	$332.7M+14.6%	$290.5M+1.7%	$285.6M-8.4%	$311.7M-2.3%	$319.2M+13.6%	$281.0M
Current Liabilities	$483.7M+34.7%	$358.9M+17.3%	$305.9M+10.9%	$275.7M+6.2%	$259.6M-7.8%	$281.5M+10.2%	$255.5M+1.1%	$252.7M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$207.8M-17.4%	-$176.9M+28.9%	-$249.0M-17.7%	-$211.5M-9.8%	-$192.6M+8.8%	-$211.3M+1.6%	-$214.7M-13.1%	-$189.8M
Retained Earnings	-$921.8M-3.7%	-$888.7M-40.7%	-$631.4M-7.2%	-$589.1M-4.6%	-$563.1M-1.2%	-$556.6M-0.8%	-$552.2M-7.3%	-$514.6M

SCLXW Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$3.8M-80.3%	$19.3M+193.4%	-$20.7M+2.6%	-$21.3M+25.8%	-$28.7M	N/A
Capital Expenditures	$133K	$0-100.0%	$30K+328.6%	$7K	$0-100.0%	$25K
Free Cash Flow	$3.7M-81.0%	$19.3M+193.3%	-$20.7M+2.5%	-$21.3M+25.8%	-$28.7M	N/A
Investing Cash Flow	$4.1M+252.7%	-$2.7M-710.6%	-$330K+84.0%	-$2.1M	$0+100.0%	-$25K
Financing Cash Flow	-$5.5M+69.9%	-$18.1M-176.9%	$23.6M+11.4%	$21.2M-24.8%	$28.2M	N/A
Dividends Paid	N/A	$8.7M0.0%	$8.7M	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Operating Cash Flow	-$17.5M-312.3%	$8.2M+16.7%	$7.0M+17.4%	$6.0M+137.1%	$2.5M-50.4%	$5.1M+121.2%	$2.3M-75.4%	$9.4M
Capital Expenditures	N/A	N/A	N/A	N/A	$0	$0	N/A	N/A
Free Cash Flow	N/A	N/A	N/A	N/A	$2.5M-50.4%	$5.1M	N/A	N/A
Investing Cash Flow	$4.8M+3247.4%	-$152K+0.7%	-$153K+61.3%	-$395K-102.6%	-$195K+91.1%	-$2.2M-1353.3%	-$150K0.0%	-$150K
Financing Cash Flow	$17.5M+255.1%	-$11.3M-31.4%	-$8.6M-178.8%	-$3.1M+57.1%	-$7.2M-60.2%	-$4.5M-194.8%	$4.7M+142.3%	-$11.2M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

SCLXW Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	-218.2%-122.3pp	-95.9%-162.3pp	66.5%-5.2pp	71.6%-16.8pp	88.4%	N/A
Operating Margin	-1143.7%-996.3pp	-147.4%+78.2pp	-225.6%-92.4pp	-133.1%-18.7pp	-114.4%	N/A
Net Margin	-1236.4%-1107.8pp	-128.7%+115.9pp	-244.6%-183.2pp	-61.4%+220.9pp	-282.4%	N/A
Return on Equity	N/A	N/A	N/A	-64.5%	N/A	N/A
Return on Assets	-102.5%-24.2pp	-78.3%+34.5pp	-112.9%-85.9pp	-27.0%+86.5pp	-113.5%	N/A
Current Ratio	0.08-0.1	0.16-0.0	0.19-0.5	0.66+0.5	0.14-0.0	0.17
Debt-to-Equity	-2.78-1.3	-1.48+0.1	-1.59-1.6	0.00+0.3	-0.32-10.0	9.65
FCF Margin	12.2%-22.0pp	34.2%+78.5pp	-44.4%+11.6pp	-55.9%+35.6pp	-91.5%	N/A

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Gross Margin	-1741.8%-1810.3pp	68.5%+1.5pp	66.9%-5.4pp	72.3%+635.8pp	-563.4%-637.3pp	73.9%+0.7pp	73.2%+8.5pp	64.7%
Operating Margin	-2317.8%-551.6pp	-1766.2%-1559.0pp	-207.2%+350.3pp	-557.5%-367.0pp	-190.5%-52.5pp	-138.0%-42.5pp	-95.4%+83.5pp	-179.0%
Net Margin	-961.9%+1479.6pp	-2441.5%-1996.4pp	-445.1%+76.1pp	-521.2%-477.8pp	-43.4%-13.0pp	-30.4%+199.2pp	-229.6%-5.6pp	-224.0%
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	-12.6%+80.8pp	-93.5%-40.9pp	-52.6%-19.6pp	-33.0%-26.1pp	-7.0%-2.6pp	-4.4%+31.6pp	-35.9%-9.2pp	-26.7%
Current Ratio	0.08+0.0	0.05-0.1	0.110.0	0.10-0.1	0.16+0.0	0.14-0.1	0.20+0.0	0.15
Debt-to-Equity	-2.78-0.2	-2.57-1.2	-1.34+0.0	-1.37+0.1	-1.480.0	-1.48+0.0	-1.490.0	-1.48
FCF Margin	N/A	N/A	N/A	N/A	17.0%-18.4pp	35.4%	N/A	N/A

Note: Shareholder equity is negative (-$207.8M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.08), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Medicus Pharma Ltd MDCX

$13.1M

Mira Pharma MIRA

$44.1M

Scilex Holding Co SCLX

$48.8M

Nasus Pharma Ltd. NSRX

$39.8M

Biofrontera BFRIW

Frequently Asked Questions

What is Scilex Holding Company's annual revenue?

Scilex Holding Company (SCLXW) reported $30.3M in total revenue for fiscal year 2025. This represents a -46.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Scilex Holding Company's revenue growing?

Scilex Holding Company (SCLXW) revenue declined by 46.5% year-over-year, from $56.6M to $30.3M in fiscal year 2025.

Is Scilex Holding Company profitable?

No, Scilex Holding Company (SCLXW) reported a net income of -$374.1M in fiscal year 2025, with a net profit margin of -1236.4%.

What is Scilex Holding Company's EBITDA?

Scilex Holding Company (SCLXW) had EBITDA of -$341.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Scilex Holding Company's gross margin?

Scilex Holding Company (SCLXW) had a gross margin of -218.2% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Scilex Holding Company's operating margin?

Scilex Holding Company (SCLXW) had an operating margin of -1143.7% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Scilex Holding Company's net profit margin?

Scilex Holding Company (SCLXW) had a net profit margin of -1236.4% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Scilex Holding Company's free cash flow?

Scilex Holding Company (SCLXW) generated $3.7M in free cash flow during fiscal year 2025. This represents a -81.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Scilex Holding Company's operating cash flow?

Scilex Holding Company (SCLXW) generated $3.8M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Scilex Holding Company's total assets?

Scilex Holding Company (SCLXW) had $365.0M in total assets as of fiscal year 2025, including both current and long-term assets.

What are Scilex Holding Company's capital expenditures?

Scilex Holding Company (SCLXW) invested $133K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Scilex Holding Company spend on research and development?

Scilex Holding Company (SCLXW) invested $20.7M in research and development during fiscal year 2025.

How many shares does Scilex Holding Company have outstanding?

Scilex Holding Company (SCLXW) had 7M shares outstanding as of fiscal year 2025.

What is Scilex Holding Company's current ratio?

Scilex Holding Company (SCLXW) had a current ratio of 0.08 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is Scilex Holding Company's debt-to-equity ratio?

Scilex Holding Company (SCLXW) had a debt-to-equity ratio of -2.78 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Scilex Holding Company's return on assets (ROA)?

Scilex Holding Company (SCLXW) had a return on assets of -102.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Why is Scilex Holding Company's debt-to-equity ratio negative or unusual?

Scilex Holding Company (SCLXW) has negative shareholder equity of -$207.8M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is Scilex Holding Company's Piotroski F-Score?

Scilex Holding Company (SCLXW) has a Piotroski F-Score of 3 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Scilex Holding Company's earnings high quality?

Scilex Holding Company (SCLXW) has an earnings quality ratio of -0.01x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Scilex Holding Company cover its interest payments?

Scilex Holding Company (SCLXW) has an interest coverage ratio of -30.2x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Scilex Holding Company?

Scilex Holding Company (SCLXW) scores 24 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.